Browse > Article
http://dx.doi.org/10.3746/jfn.2006.11.1.054

Immunomodulatory Effect of a New Herbal Preparation (HemoHIM) in Cyclophosphamide-treated Mice  

Park, Hae-Ran (Radiation Biotechnology Research Team, Advanced Radiation Technology Institute, Jeongeup Campus of Korea Atomic Energy Research Institute (KAERI))
Jo, Sung-Kee (Radiation Biotechnology Research Team, Advanced Radiation Technology Institute, Jeongeup Campus of Korea Atomic Energy Research Institute (KAERI))
Jung, U-Hee (Radiation Biotechnology Research Team, Advanced Radiation Technology Institute, Jeongeup Campus of Korea Atomic Energy Research Institute (KAERI))
Kim, Sung-Ho (College of Veterinary Medicine, Chonnam National University)
Yee, Sung-Tae (Department of Biology, Sunchon National University)
Publication Information
Preventive Nutrition and Food Science / v.11, no.1, 2006 , pp. 54-60 More about this Journal
Abstract
The immunomodulatory effect of a new herbal preparation, HemoHIM, on the recovery from leukopenia induced by cyclophosphamide treatment was investigated. The HemoHIM was made up with an addition of the ethanol-insoluble fraction to the total water extract of Angelica Radix, Cnidii Rhizoma and Paeonia Radix. Daily oral administration of 100 mg/kg BW or 500 mg/kg BW HemoHIM accelerated the recovery from cyclophosphamide-induced leukopenia. HemoHIM increased the number of leukocytes and lymphocytes in the peripheral blood when compared with the cyclophosphamide-treated control. Moreover, the suppressed natural killer (NK) cell activity and interferon $(IFN)-{\gamma}$ secretion in the cyclophosphamide-treated mice were restored by the administration of HemoHIM. HemoHIM significantly reduced the abnormally heightened ratio of interleukin $(IL)-4/IFN-{\gamma}$ and immunoglobulin (Ig)E/IgG2a in the cyclophosphamide-treated mice. These results suggest that HemoHIM accelerates the recovery from leukopenia and alleviates the imbalanced T helper (Th)l/Th2 responses in the cyclophosphamide-treated mice. Additionally, HemoHIM was found to stimulate normal splenocytes to secrete not only Thl type cytokines such as $IFN-{\gamma}$ and IL-2, but also Th2 type cytokine IL-4. In conclusion, our results show that HemoHIM certainly has an influence on the balanced recovery of immune cells and the activation of their activities in the cyclophosphamide-treated mice.
Keywords
immune; modulatory; herbal; Th1/Th2 balance; cyclophosphamide;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Jin R, Wan LL, Mitsuishi T, Sato S, Akuzawa Y, Kodama K, Kurashige S. 1994. Effect of shi-ka-ron and Chinese herbs on cytokine production of macrophage in immunocompromised mice. Am J Chin Med 22: 255-266   DOI   ScienceOn
2 Xu X, Malave A. 2001. Protective effect of berberine on cyclophosphamide-induced haemorrhagic cystitis in rats. Pharmacol Toxicol 88: 232-237   DOI   ScienceOn
3 Allison AC. 2000. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 47: 63-83   DOI   ScienceOn
4 Sasaki G, Satoh T, Yokozeki H, Katayama I, Nishioka K. 2000. Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity: Functional roles of inter-leukin-5-producing $CD4^+$ lymphocytes. Cellular Immunol 203: 124-133   DOI   ScienceOn
5 Constant SL, Bottomly K. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Ann Rev Immunol 15: 297-322   DOI   ScienceOn
6 Moody DJ, Fahey JL, Grable E, Ellison GW, Myers LW. 1987. Administration of monthly pulses of cyclophos-phamide in multiple sclerosis patients. Delayed recovery of several immune parameters following discontinuation of long-term cyclophosphamide treatment. J Neuroimmunol 13: 175-182   DOI   ScienceOn
7 Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL. 2004. Cyclophosphamide modulates $CD4^+$ T cells into a T helper type 2 phenotype and reverses increased IFN-${\gamma}$production of $CD8^+$ T cells in secondary progressive multiple sclerosis. J Neuroimmunol 146: 189-198   DOI   ScienceOn
8 Brinkman CJ, Nillesen WM, Hommes OR. 1984. The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis. Acta Neurol Scand 69: 90-96   DOI   ScienceOn
9 Kaneko M, Kawakita T, Kumazawa Y, Takimoto H, Nomoto K, Yoshikawa T. 1999. Accelerated recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herbal drug, Hochu-ekki-to. Immunopharmacology 44: 223-231   DOI   ScienceOn
10 Chu DT, Wong WL, Mavligit GM. 1988. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophos-phamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 25: 125-129
11 O'Garra A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283   DOI   ScienceOn
12 Weiner HL, Cohen JA. 2002. Treatment of multiple sclerosis with cyclophosphamide: critical review of clin-ical and immunologic effects. Mult Scler 8: 142-15   DOI
13 Jo SK, Park HR, Jung UH, Oh H, Kim SH, Yee ST. 2005. Protective effect of a herbal preparation (HemoHIM) on the self-renewal tissues and immune system against ${\gamma}$- irradiation. J Korean Soc Food Sci Nutr 34: 805-813   과학기술학회마을   DOI   ScienceOn
14 Paul WE, Seder RA, Plaut M. 1993. Lymphokine and cytokine production by Fc${\varepsilon}$RI cells. Adv Immunol 53: 1-29   DOI
15 Smith DR, Balashov KE, Hafler DA, Khoury SJ, Weiner HL. 1997. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosino-philia. Ann Neurol 42: 313-318   DOI   ScienceOn
16 Romagnani S. 1997. The Th1/Th2 paradigm. Immunol Today 18: 263-266
17 Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383: 787-793   DOI   ScienceOn
18 Kajioka EH, Andres ML, Li J, Mao XW, Moyers MF, Nelson GA, Slater JM, Gridley DS. 2000. Acute effects of whole-body proton irradiation on the immune system of the mouse. Radiat Res 153: 587-594   DOI   ScienceOn
19 Coffman RL, Catry J. 1986. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-${\gamma}$. J Immunol 136: 949-954
20 Comabella M, Balashov K, Issazadeh S, Smith D, Weiner HL, Khoury SJ. 1998. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest 102: 671-678   DOI   ScienceOn
21 Nadler MJ, Matthews SA, Turner H, Kinet JP. 2000. Signal transduction by the high affinity immunoglobulin E receptor Fc${\varepsilon}$RI: coupling form to function. Adv Immunol 76: 325-35   DOI
22 Park HR, Kim SH, Yee ST, Byun MW, Jo SK. 2005. Effect of a herb mixture (HIM-I) on the protection of the hematopoietic-immune system and self-renewal tissues against radiation damage. J Korean Soc Food Sci Nutr 34: 605-612   과학기술학회마을   DOI   ScienceOn
23 Takashima H, Smith DR, Fukaura H, Khoury SJ, Hafler DA, Weiner HL. 1998. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients. Clin Immunol Immunopathol 88: 28-34   DOI   ScienceOn
24 Snapper CM, Paul WE. 1987. Interferon-${\gamma}$ and B cell stimulatory-factor-I reciprocally regulate Ig isotype pro-duction. Science 236: 944-947   DOI
25 Mosmann TR, Coffman RL. 1998. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7: 145-171   DOI   ScienceOn